ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9467
-1.20%
Brent Oil
83.54
-2.74%
Bitcoin
58,325.75
-3.75%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) Noticias

LUNG Pulmonx Corporation

9.67
2.06 (27.07%)
Fuera de horario
Última actualización: 18:28:51
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pulmonx Corporation LUNG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
2.06 27.07% 9.67 18:28:51
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
7.70 7.64 8.15 7.72 7.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:05GLOBEPulmonx Reports First Quarter 2024 Financial Results
10/4/202415:05GLOBEPulmonx to Report First Quarter 2024 Financial Results on..
02/4/202415:05GLOBEPulmonx Announces Appointment of Mehul Joshi as Chief..
15/3/202416:00GLOBEPulmonx Announces Inducement Grants under Nasdaq Listing..
07/3/202419:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
05/3/202417:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/2/202415:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202419:48BWPulmonx meldet Behandlung des ersten Patienten mit dem..
26/2/202419:40BWPulmonx annonce le traitement du premier patient par système..
26/2/202419:39BWPulmonx annuncia il trattamento del primo paziente con il..
26/2/202417:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202407:00BWPulmonx Announces Treatment of the First Patient with the..
22/2/202415:31EDGAR2Form 144 - Report of proposed sale of securities
21/2/202415:08EDGAR2Form 8-K - Current report
21/2/202415:06GLOBEPulmonx Reports Fourth Quarter and Full Year 2023 Financial..
21/2/202415:05EDGAR2Form 8-K - Current report
21/2/202415:05GLOBEPulmonx Announces Retirement of CEO Glen French and..
16/2/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:14EDGAR2Form 144 - Report of proposed sale of securities
14/2/202405:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202416:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:05GLOBEPulmonx to Report Fourth Quarter and Full Year 2023..
31/1/202415:34EDGAR2Form 144 - Report of proposed sale of securities
24/1/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202415:28EDGAR2Form 144 - Report of proposed sale of securities
18/1/202416:06EDGAR2Form 144 - Report of proposed sale of securities
27/12/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202317:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:25EDGAR2Form 144 - Report of proposed sale of securities
21/12/202315:43EDGAR2Form 144 - Report of proposed sale of securities
11/12/202308:00GLOBEThe Honest Company Announces Appointment of Michael Barkley,..
05/12/202316:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202315:24EDGAR2Form 144 - Report of proposed sale of securities
15/11/202315:05GLOBEPulmonx to Present at the Piper Sandler 35th Annual..
03/11/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202315:05GLOBEPulmonx to Participate at Upcoming Investor Conferences
30/10/202315:06EDGAR2Form 8-K - Current report
30/10/202315:05GLOBEPulmonx Reports Record Third Quarter 2023 Financial Results
25/10/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202316:10EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
LUNG
Pulmonx
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados